0000950170-24-072505.txt : 20240612 0000950170-24-072505.hdr.sgml : 20240612 20240612163538 ACCESSION NUMBER: 0000950170-24-072505 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240606 FILED AS OF DATE: 20240612 DATE AS OF CHANGE: 20240612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REINHARDT MAX CENTRAL INDEX KEY: 0001780058 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19961 FILM NUMBER: 241038873 MAIL ADDRESS: STREET 1: C/O PACIRA BIOSCIENCES, INC. STREET 2: 5401 WEST KENNEDY BOULEVARD, SUITE 890 CITY: TAMPA STATE: FL ZIP: 33609 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Orthofix Medical Inc. CENTRAL INDEX KEY: 0000884624 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 FISCAL YEAR END: 1223 BUSINESS ADDRESS: STREET 1: 3451 PLANO PARKWAY CITY: LEWISVILLE STATE: TX ZIP: 75056 BUSINESS PHONE: 214-937-2000 MAIL ADDRESS: STREET 1: 3451 PLANO PARKWAY CITY: LEWISVILLE STATE: TX ZIP: 75056 FORMER COMPANY: FORMER CONFORMED NAME: ORTHOFIX INTERNATIONAL N V DATE OF NAME CHANGE: 19970708 4 1 ownership.xml 4 X0508 4 2024-06-06 0000884624 Orthofix Medical Inc. OFIX 0001780058 REINHARDT MAX 3451 PLANO PARKWAY LEWISVILLE TX 75056 false true false false President, Global Spine false Common Stock 2024-06-10 4 A false 14401 13.02 A 14401 D Employee Stock Option (Right to Buy) 13.02 2024-06-10 4 A false 190731 0 A 2031-06-10 Common Stock 190731 190731 D The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date. 33,103 of the stock options vest upon achievement of both service- and performance-based criteria, whichever is the later of (a) the date certain service-based conditions are met (which will be met over three years) and (b) the date that the average closing price of the Company's common stock over a one-month calendar period has been equal to or great than 150% of the closing price of the Company's common stock on the grant date. The remaining 157,628 stock options vest on the third anniversary of the grant date. /s/ J. Andres Cedron, attorney-in-fact 2024-06-12